Instruction for use: Immunoglobulinum humanum normale

Dosage form: Solution for intravenous administration; Solution for intramuscular administration; Solution for infusions

Active substance: Immunoglobulinum humanum normale

ATX

J06BA01 Normal human immunoglobulin for intramuscular injection

Pharmacological group:

Immunoglobulins

The nosological classification (ICD-10)

A37 Pertussis: Bacterial transport of pertussis pathogens; Whooping cough

A39 Meningococcal infection: Asymptomatic carriage of meningococci; Infection of meningococcal; Meningococcus aureus; The epidemic of meningitis

B05 Measles: Koplik Spots; Koryvyaya rash on the mucous cheek

B19 Viral hepatitis, unspecified: Anemia without hepatitis; Viral hepatitis; Viral hepatitis in children; Infection of the liver; Acute liver infection

B91 Consequences of poliomyelitis: Poliomyelitis consequences; Post-poliomyelitis syndrome

E88.0 Disorders of plasma protein metabolism, not elsewhere classified: Hypoalbuminemia; Hypoproteinemia; Lysinemia

Composition and release form

1 ampoule contains 1.5 ml of solution for injection; In the package 10 pcs.

Characteristic

A protein fraction isolated from human serum or plasma, purified and concentrated by the ethanol fractionation method.

Pharmachologic effect

Mode of action - immunostimulating.

Indication of the Immunoglobulinum humanum normale

Hypo-and agammaglobulinemia, reduced resistance of the organism; Prevention of hepatitis A, measles, whooping cough, meningococcal infection, poliomyelitis.

Contraindications

Severe allergic reactions to the introduction of blood products in the anamnesis.

Side effects

Anaphylactic shock, hyperemia at the injection site.

Dosing and Administration

The drug is administered only IM in the upper outer quadrant of the gluteus muscle or in the external surface of the thigh. The dose and the frequency of administration depend on the indications for use.

Precautionary measures

Persons suffering from immunopathological systemic diseases (blood diseases, connective tissue, nephritis, etc.), the drug should be administered against the background of appropriate therapy. When pregnancy and breast-feeding are used only as prescribed by the doctor. The interval between prescribing and vaccination against measles and mumps should be at least 2-3 months.

Storage conditions of the drug Immunoglobulinum humanum normale

In a dry place, at a temperature of 2-8 ° C (do not freeze).

Keep out of the reach of children.

Shelf life of the drug Immunoglobulinum humanum normale

2 years.

Do not use after the expiry date printed on the package.